https://www.selleckchem.com/pr....oducts/ccg-203971.ht
001). Also on measuring the risk estimate, a significant difference (odd's ratio was 3.76, 95% confidence interval was 1.68-8.4, P = 0.001). While no statistical significant difference in genotype frequency was found between the obese and overweight patients (P 0.05). Median serum adiponectin level was decreased in BC patients compared to the control group (8.9 vs. 14.6 with P = 0.004). This study supported the association between adiponectin gene polymorphism, serum level, and BC risk among a group of obese and overweight postm
Like
Comment
Share
